롱
Hey Albert David ! Time for your Bid !
- Company is almost debt free.
- Company has delivered good profit growth of 35.0%
CAGR over last 5 years
- Dividend Yield 1.12 %
- PE 8 vs Industry PE of 29
Albert David Ltd is engaged in manufacturing and trading of Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms and Bulk Drugs by way of domestic sale or export.
During FY22, the Co. introduced two products i.e., Evacure and C3H in the market. It is expected that these two products will augment the revenue and profits of the Company.
The Co. will continue to focus on enhancing its presence organically as well as inorganically, both in the domestic and the international market.
- Company has delivered good profit growth of 35.0%
CAGR over last 5 years
- Dividend Yield 1.12 %
- PE 8 vs Industry PE of 29
Albert David Ltd is engaged in manufacturing and trading of Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms and Bulk Drugs by way of domestic sale or export.
During FY22, the Co. introduced two products i.e., Evacure and C3H in the market. It is expected that these two products will augment the revenue and profits of the Company.
The Co. will continue to focus on enhancing its presence organically as well as inorganically, both in the domestic and the international market.
면책사항
해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.
면책사항
해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.